Unlocking liquid science markets through tokenized IP
- Tweets 6,749
- Following 2,025
- Followers 30,371
- Likes 9,493
Molecule retweeted
Molecule's initial intellectual property primitive was highlighted in a paper from @GoogleDeepMind's research team: "Agentic Economies for Autonomous Scientific Discovery"
We believe the future sits at the intersection of scientific, technological, and legal innovation.
Happy to share a new preprint: "Agentic Economies for Autonomous Scientific Discovery"
arxiv.org/abs/2609.31562
that encapsulates our thoughts on the AI revolution in science, and how applying an economic lens enables us to better recognize the key bottlenecks and how to address them.
2
4
20
2,202
Molecule retweeted
Our team was in Zurich hosted by RoX Health, the digital health innovation studio of @Roche, to discuss AI's role in biotech research.
From @RafaDeSci "Really great scope of attendees, who keep validating our thesis of how we see AI incorporated in biotech and pharma."
1
16
1,211
Molecule's initial intellectual property primitive was highlighted in a paper from @GoogleDeepMind's research team: "Agentic Economies for Autonomous Scientific Discovery"
We believe the future sits at the intersection of scientific, technological, and legal innovation.
Happy to share a new preprint: "Agentic Economies for Autonomous Scientific Discovery"
arxiv.org/abs/2609.31562
that encapsulates our thoughts on the AI revolution in science, and how applying an economic lens enables us to better recognize the key bottlenecks and how to address them.
2
4
20
2,202
For those of you curious about whats happened in the four years since the IP-NFT was launched - our recent protocol whitepaper covers our development. We'd love to know what you think.
molecule.xyz/blog/molecule-p…
1
3
155
Our thanks to @weballergy, @FranklinMatija, @sebkrier, @sindero, @Dr_Atoosa, @vivnat & @alan_karthi for sharing your insights on the AI revolution in science.
Full paper is linked below arxiv.org/abs/2609.31562
3
107
Our team is in Zürich this Wednesday, hosted by RoX Health, the digital health innovation studio of @Roche!
They will talk about how agentic AI & frontier models are shaping the healthcare value chain, from lab-in-the-loop discovery to data analytics.
4
2
20
2,626
Biotechnology is increasingly looking like a collaboration between computer scientists and healthcare scientists - if you are either of those, you should attend the session.
1
1
189
Westhive, Hardturmstrasse 161, Wednesday 23 September, with registration subject to host approval: luma.com/we40h98y
138
Molecule retweeted
If you're in Zurich next Wed (23rd), we'll be chatting about analyzing your own genome @dark_dot_bio, next-gen sequencing @Roche, and agentic drug discovery @rafadesci. ~30 of us, live demos, sharing what works and importantly what doesn't. Register: luma.com/we40h98y
2
2
907
We're hosting an AI roundtable at the LSTN event in Berlin: AI workflows that keep the scientist in the loop. It covers where a research workflow hands off to a person, and what that person needs before acting on a model's output.
Registration: luma.com/7rl80ns2?tk=qVe6PG
4
2
9
1,337
Autonomous research agents can generate more hypotheses in an afternoon than a lab can test in a year.
The design question is where the handoffs sit. A model's output needs to start committing to a budget, and whoever signs off on that needs to see how the output was reached.
1
1
285
Martin Karlsson (@jmartink) and Stefan Adolf (@stadolf) are running the table. Berlin, Monday 21 September, 18:30, alongside five other roundtables that evening.
luma.com/7rl80ns2?tk=qVe6PG
1
217
Two mathematicians may have watched their own unpublished work help solve a Millennium Prize problem, and watched OpenAI claim credit.
Tristan Buckmaster and Levent Alpöge spent months on a problem that has resisted proof for more than a century, and like a lot of researchers this year, they worked with an AI assistant beside them. They put drafts and half-formed arguments through Codex as they went, the ordinary mess of working towards something.
Then - this week OpenAI announced that an internal model had resolved a version of the Navier-Stokes problem. The researchers reached out to ask the obvious question; did their work train OpenAI's models? OpenAI's answer was that it had not accessed their user data, though it "cannot rule out that de-identified data derived from their usage of our products helped improve our models."
We congratulate Levent Alpöge and Tristan Buckmaster on their remarkable mathematical work.
We (the researchers and the agents) did not see any of their work through any means until they released it publicly — in particular, no specific user data was accessed in order to solve this problem.
While unlikely, we cannot rule out that de-identified data derived from their usage of our products helped improve our models.
However, our proofs differ significantly and even the precise results proved are different in the Euler case (forced vs. unforced).
1
9
1,910
Labs was built so the record already exists by the time it is needed. Every file uploaded to a Lab receives a content identifier derived cryptographically from its contents, so a single altered byte produces an entirely different identifier. That identifier is recorded within a Lab with a timestamp, the author's identity, and a pointer back to the version before it, in an append-only history that cannot be manipulated. A file marked confidential stays encrypted and closed while its existence, its timing and its authorship stay verifiable by anyone.
This is legitimately terrible for OpenAI --- but also Anthropic --- and it relates to their work in drug discovery.
I read this as: prompts will be monitored and potentially acted on if we think there’s something scientifically and/or commercially valuable being disclosed.
Now, the big problem for Anthropic is that they are increasingly seen to be competing with their customers. Outside of SF, many people also think of OpenAI/ChatGPT and Anthropic/Claude as somewhat interchangeable companies and products --- aka, if OpenAI do something, surely Anthropic will do it too?
As so much IP relates to drug targets and people disclose these to Claude, I think we will see a lot of pharma companies stop using these tools or put up a lot of internal guardrails.
1
1
248
Proof, without needing to show your hand.
We've written a summary explaining how we're thinking about the next wave of AI-augmented biological discovery.
As discovery accelerates, attribution becomes the harder problem. With Molecule Labs, a verifiable and traceable record of your science is created at every step.
1
3
183